BODI vs ARQ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

BODI

55.1
AI Score
VS
BODI Wins

ARQ

50.2
AI Score

Investment Advisor Scores

BODI

55score
Recommendation
HOLD

ARQ

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BODI ARQ Winner
Forward P/E 29.8507 63.2911 BODI
PEG Ratio 0 11.7462 Tie
Revenue Growth -25.0% 6.6% ARQ
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.1/100 50.2/100 BODI
Profit Margin 2.2% -43.9% BODI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BODI 1M: -6.2% · 3M: -32.5% ARQ 1M: -10.4% · 3M: -11.1%

Current Technical Phase

BODI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -10.0%) with fading momentum, RSI 45

RSI (14): 45.2 · Price: $10.12

ARQ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 41

RSI (14): 41.1 · Price: $2.04

Fundamentals Snapshot

Metric BODI ARQ
Market Cap
Forward P/E 9.4 -28.1
Trailing P/E 14.1
Revenue (TTM)
Revenue Growth -0.3% 0.1%
Gross Margin 0.7% 0.3%
Operating Margin 0.1% 0.0%
EPS 0.71 -1.37
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BODI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.